Vidaza and anaemia Patient Reports February 11, 2012

Vidaza Side Effects Report #4635665-2
Vidaza side effect was reported by a Physician from on Mar 31, 2005. Female patient, 83 years of age, weighting 118.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agitation, anaemia, coma, gastrointestinal haemorrhage, myoclonus, neuropathy, thrombocytopenia, white blood cell count decreased. Vidaza dosage: 115 MG, SUBCUTAENOUS. During the same period patient was treated with THALOMID, VERAPAMIL, ASPIRIN, DILANTIN, OCUVITE, ZANTAC, PULMICORT, ATROVENT. Patient was hospitalized. Patient died on 11/30/2004.

Vidaza Side Effects Report #4615678-7
Vidaza side effect was reported by a Physician from on Mar 03, 2005. Male patient, 82 years of age, weighting 138.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal discomfort, anaemia, asthenia, atelectasis, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, febrile neutropenia, infection . Vidaza dosage: 75 MG/M2 (127 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with PROCRIT, NEUPOGEN, ZOLOFT, TARKA, PRINIVIL, ASPIRIN, PLAVIX. Patient was hospitalized. Patient died on 08/31/2004.

Vidaza Side Effects Report #5145543-0
Vidaza side effect was reported by a Physician from UNITED STATES on Oct 17, 2006. Female patient, 79 years of age, weighting 183.4 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, dilatation atrial, epistaxis, thrombocytopenia, ventricular extrasystoles, ventricular hypertrophy. Vidaza dosage: 75 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with MGCD, SPIRIVA, ADVAIR DISKUS, FLONASE, ALLEGRA, ZOLOFT, FOLATE, METAMUCIL. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5367782-6
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 04, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, haemolysis, nausea , polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS), INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.


Vidaza Side Effects Report #5380511-5
Vidaza side effect was reported by a Physician from UNITED KINGDOM on June 21, 2007. Male patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, nausea , polychromasia, red blood cell spherocytes present. Vidaza dosage: 75 MG/M2 (DAILY X 5 DAYS),INTRAVENOUS. During the same period patient was treated with LEVOTHYROXINE, ACYCLOVIR. Patient recovered.

Vidaza Side Effects Report #4822196-X
Vidaza side effect was reported by a Physician from UNITED STATES on Oct 25, 2005. Female patient, 63 years of age, weighting 147.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, cerebral haematoma, haemorrhage intracranial, international normalised ratio increased, leukaemia cutis, loss of consciousness, mental status changes, platelet count decreased, purpura. Vidaza dosage: 70 MG/M2 (125 MG), SUBCUTANEOUS. During the same period patient was treated with DESFERAL, PROCRIT, VITAMIN C. Patient was hospitalized. Patient died on 07/20/2004.

Vidaza Side Effects Report #5443288-0
Vidaza side effect was reported by a Physician from GERMANY on Aug 16, 2007. Male patient, 59 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, aplasia, atrial fibrillation , catheter site haemorrhage, convulsion, febrile neutropenia, haemoptysis, left ventricular failure. Vidaza dosage: (100 MG/M2), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, NEUPOGEN. Patient was hospitalized. Patient died on 07/15/2007.

Vidaza Side Effects Report #4811535-1
Vidaza side effect was reported by a Physician from POLAND on Oct 10, 2005. Female patient, 53 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal distension, acute pulmonary oedema, anaemia, asthenia, atrial fibrillation , blood glucose increased, cardiogenic shock, gastrointestinal haemorrhage. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ENCORTON, POLPRAZOL, DIAPREL, HEMOROL, PROPRANOLOL, ENALAPRIL MALEATE, SPIRONOL, FLUCONAZOLE. Patient was hospitalized. Patient died on 10/03/2005.

Vidaza Side Effects Report #5972614-9
Vidaza side effect was reported by a Consumer or non-health professional from AUSTRALIA on Nov 18, 2008. Male patient, weighting 156.1 lb, was diagnosed with myelodysplastic syndrome, arthritis , pain  and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, colitis ischaemic, gastrointestinal haemorrhage, infection . Vidaza dosage: unknown. During the same period patient was treated with THALIDOMIDE, ACETAMINOPHEN, ACETAMINOPHEN W, PANADEINE OSTEO, SOMAC, CLEXANE. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5626392-3
Vidaza side effect was reported by a Physician from GERMANY on Feb 01, 2008. Female patient, 68 years of age, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, cachexia, confusional state, diarrhoea, leukoencephalopathy, thrombocytopenia. Vidaza dosage: (75 MG/M2, DAILY X7 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5663653-6
Vidaza side effect was reported by a Physician from GERMANY on Feb 27, 2008. Female patient, 68 years of age, weighting 94.80 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, cachexia, diarrhoea, leukoencephalopathy, performance status decreased, thrombocytopenia. Vidaza dosage: 75 MG/M2, DAILY X 7, SUBCUTANEOUS. During the same period patient was treated with ACYCLOVIR, ESOMEPRAZOLER, COTRIMTE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5237948-4
Vidaza side effect was reported by a Physician from PHILIPPINES on Feb 01, 2007. Female patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anaemia, arrhythmia , asthenia, disease progression, platelet count decreased. Vidaza dosage: 50 MG/M2 (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with NASEA, DEPAKOTE. Patient died on 01/18/2007.